ExodusPoint Capital Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

ExodusPoint Capital Management’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-4,694	Closed	-$246K	–	2583
2020 Q3	$246K	Buy	+4,694	New	+$194K	﹤0.01%	1382
2019 Q3	–	Sell	-11,844	Closed	-$147K	–	1764
2019 Q2	$147K	Buy	+11,844	New	+$157K	0.01%	983

ExodusPoint Capital Management's MNTA Position: Q4 2020 in Review

ExodusPoint Capital Management sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 4,694 shares — an estimated $246K sold.

ExodusPoint Capital Management first reported a position in MNTA in Q2 2019 and held it in 2 quarters. The position peaked at $246K in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.

ExodusPoint Capital Management reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
ExodusPoint Capital Management sold 4,694 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $246K.
ExodusPoint Capital Management first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2019 and held it in 2 quarters.
ExodusPoint Capital Management's Momenta Pharmaceuticals, Inc. position peaked at $246K in Q3 2020.
0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.

Based on ExodusPoint Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.